
Sign up to save your podcasts
Or


A surgeon in burns reconstruction, Matt Klein swapped the operating room for the equally high-pressure environment of drug development. In this episode of Pathfinders in Biopharma, he sets out the vision for the company he now leads, PTC Therapeutics – a pioneer in the field of RNA therapies, now powering towards profitability with treatment candidates for a host of rare diseases.
By RBC Capital Markets5
1212 ratings
A surgeon in burns reconstruction, Matt Klein swapped the operating room for the equally high-pressure environment of drug development. In this episode of Pathfinders in Biopharma, he sets out the vision for the company he now leads, PTC Therapeutics – a pioneer in the field of RNA therapies, now powering towards profitability with treatment candidates for a host of rare diseases.

3,220 Listeners

1,707 Listeners

965 Listeners

1,944 Listeners

1,646 Listeners

1,087 Listeners

125 Listeners

321 Listeners

1,039 Listeners

1,298 Listeners

6,078 Listeners

34 Listeners

40 Listeners

19 Listeners

10 Listeners

0 Listeners

81 Listeners

18 Listeners

13 Listeners

3 Listeners